Quanterix | 10-K/A: Annual report (Amendment)
Quanterix Shareholder Issues Statement on Akoya Biosciences Merger Pact
Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Leerink Partners Downgrades Quanterix to Market Perform, Lowers Price Target to $8
Quanterix Analyst Ratings
Quanterix Faces Strategic and Financial Challenges Amid Akoya Acquisition and Market Pressures
Express News | Quanterix Corp : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $8 From $12
Quanterix: In Light of Recent Volatility, We Re-Engaged With Akoya to Revise the Terms of the Agreemen >QTRX
Quanterix Will Issue Over 9 M Fewer Shrs Than Under the Original Deal Terms >QTRX
Express News | Quanterix Corp - Akoya Shareholders to Receive $0.38 Cash and 0.1461 Quanterix Shares
Press Release: Quanterix and Akoya Biosciences Announce Amended Merger Agreement
Strong Week for Quanterix (NASDAQ:QTRX) Shareholders Doesn't Alleviate Pain of Five-year Loss
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
Top Premarket Gainers
Quanterix (QTRX) Receives a Buy From Leerink Partners
Kent Lake, A 7.7% Shareholder Of Quanterix Announces It Has Filed A Definitive Proxy Statement With The U.S. SEC And Sent Letter To Quanterix Shareholders In Connection With Its Opposition To The Company's Proposed Merger With Akoya Biosciences
Express News | Kent Lake: Urges Quanterix Shareholders to Vote Against Akoya Merger Proposals
Express News | Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders